Related Experiment Video
Updated: Jun 10, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.
1Division of Molecular and Cellular Biology, Research Institute, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
Leukemia
|July 30, 2010
Summary
Chronic lymphocytic leukemia (CLL) cells show elevated O-linked N-Acetylglucosamine (O-GlcNAc) levels, impacting signaling. High O-GlcNAc correlates with disease behavior, suggesting therapeutic potential.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Aberrant cellular signaling is a hallmark of chronic lymphocytic leukemia (CLL).
- O-linked N-Acetylglucosamine (O-GlcNAc) is a post-translational modification regulated by the hexosamine pathway, influencing intracellular signaling.
- The role of O-GlcNAcylation in CLL pathogenesis is not well understood.
Purpose of the Study:
- To investigate O-GlcNAcylated protein levels in primary CLL cells.
- To determine the relationship between O-GlcNAcylation and CLL cell signaling responses.
- To explore the correlation between O-GlcNAc levels and clinical behavior in CLL.
Main Methods:
- Quantification of O-GlcNAcylated proteins in primary CLL cells and normal B cells.
- Assessment of O-GlcNAc levels following cellular activation (cytokines, TLRs) and hexosamine pathway substrate loading.
- Analysis of signaling responses to various stimuli (TLR agonists, chemotherapy, BCR crosslinking, mitogens) in relation to O-GlcNAc levels.
- Correlation of O-GlcNAc levels with indolent and aggressive CLL clinical behavior.
Main Results:
- CLL cells exhibited significantly higher O-GlcNAcylated protein levels compared to normal B cells, including key proteins like p53, c-myc, and Akt.
- O-GlcNAcylation levels in CLL cells increased upon activation via cytokines, toll-like receptors (TLRs), or hexosamine pathway substrate loading.
- Elevated baseline O-GlcNAc levels were associated with impaired signaling responses to multiple stimuli, including TLR agonists, chemotherapeutic agents, B cell receptor crosslinking, and mitogens.
- Higher O-GlcNAc levels correlated with indolent CLL, while lower levels were associated with aggressive disease behavior.
Conclusions:
- Intracellular O-GlcNAcylation is elevated in CLL cells and is linked to altered signaling pathways.
- O-GlcNAc levels in CLL cells correlate with disease aggressiveness and clinical behavior.
- Targeting O-GlcNAcylation pathways may represent a novel therapeutic strategy for CLL.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...